News

Lilly said the extra investment at the nearly 600-acre site in Lebanon will enhance its capacity to manufacture tirzepatide, the active ingredient in both Mounjaro and Zepbound.
LEBANON, Ind. — Eli Lilly and Company announced it has more than doubled its investment in its Lebanon manufacturing site. The new $5.3 billion commitment increases the company's total ...
Lilly’s previous investment announcements for the site were an initial $2.1 billion in May 2022, an additional $1.6 billion in April 2023, and an additional $5.3 billion in May 2024.
Eli Lilly and Company kicked off the second day of the Indiana Global Economic Summit by announcing a $5.3 billion investment slated for a major tech park.
May 24—Eli Lilly and Co. announced this week that it will boost its investment in Lebanon to $9 billion. The company initially announced a $2.1 billion investment in May of 2022 but boosted that ...
In May 2022, Lilly first announced its plans to invest $2.1 billion and create up to 500 new jobs in Lebanon. At the Lebanon groundbreaking in April 2023, Lilly announced an additional $1.6 ...
Eli Lilly and Company has announced it will be investing $2.1 billion in two new manufacturing sites at Indiana's LEAP Lebanon Innovation and Research District in Boone County.
We believe the new facility—and Lilly’s broader investments in Lebanon—help maintain Indiana as a leader of advanced manufacturing while also making it known as a state where important ...
LEBANON, Ind. — Indianapolis-based pharmaceutical giant Lilly on Wednesday announced another billion-dollar project coming to Boone County. The project will be in the LEAP Research and Innovation ...
In May 2022, Lilly announced plans to invest $2.1 billion in two new manufacturing sites in Lebanon to expand its network for active ingredients and new modalities, such as genetic medicines.
(The Center Square) – Eli Lilly and Company kicked off the second day of the Indiana Global Economic Summit by announcing a $5.3 billion investment slated for a major tech ...